| 1 |
Marko Usaj |
The Nielsen Company (Us) |
26 |
| 2 |
Valter Svara |
Titus D.O.O. Dekani |
19 |
| 3 |
Boris Stanic |
— |
7 |
| 3 |
Igor Juri{hacek over (c)}ev |
Raycap Ip Development |
7 |
| #5 |
Matja{hacek over (z)} Finc |
The Nielsen Company (Us) |
4 |
| #6 |
Gverino Ratosa |
— |
3 |
| #6 |
Svara Valter |
Titus D.O.O. Dekani |
3 |
| #6 |
Bla{hacek over (z)} Rem{hacek over (s)}kar |
The Nielsen Company (Us) |
3 |
| #6 |
Iztok Savnik |
Yahoo Japan |
3 |
| #10 |
Jure Letonje |
Efaflex Inzeniring D.O.O. Ljubljana |
2 |
| #10 |
Matjaz Finc |
The Nielsen Company (Us) |
2 |
| #10 |
Franc Banko |
Lama D. D. Dekani |
2 |
| #10 |
Matej Bazec |
Institut Jozef Stefan |
2 |
| #10 |
Jurij Letonje |
— |
2 |
| #10 |
Borut Baricevic |
— |
2 |
| #10 |
Ales Podgronik |
Bia Separations D.O.O. |
2 |
| #17 |
Emanuel Penko |
Titus D.O.O. Dekani |
1 |
| #17 |
Joze Lorbek |
— |
1 |
| #17 |
Sergio Gobbo |
— |
1 |
| #17 |
Aleksander Tomic |
— |
1 |
| #17 |
Jozef Lorbek |
— |
1 |
| #17 |
Jernej Zivic |
— |
1 |
| #17 |
Valter {hacek over (S)}vara |
Lama D. D. Dekani |
1 |
| #17 |
Jan Preseren |
— |
1 |
| #17 |
Miha Akrapovic |
— |
1 |
| #17 |
Mihaela {hacek over (S)}kulj |
Lek Pharmaceuticals D. D. |
1 |
| #17 |
Igor Juricev |
— |
1 |
| #17 |
Sa{hacek over (s)}a Stojkovic |
Lek Pharmaceuticals D. D. |
1 |
| #17 |
Vatroslav Spudic |
Lek Pharmaceuticals D. D. |
1 |
| #17 |
Matja{hacek over (z)} Koncilja |
Lek Pharmaceuticals D. D. |
1 |
| #17 |
Matja{hacek over (z)} Tisu |
Lek Pharmaceuticals D. D. |
1 |
| #17 |
Toma{hacek over (z)} {hacek over (S)}tebe |
— |
1 |
| #17 |
Andrej Mahnic |
— |
1 |
| #17 |
Joze Brezec |
— |
1 |
| #17 |
Franc Branko Cerkvenik |
— |
1 |
| #17 |
Janko Gobbo |
— |
1 |
| #17 |
Edi Belic |
— |
1 |
| #17 |
Peter Sik |
The Nielsen Company (Us) |
1 |
| #17 |
Drago Cendak |
— |
1 |
| #17 |
Kristjan A{hacek over (z)}man |
— |
1 |
| #17 |
Klemen Peterlin |
— |
1 |
| #17 |
Matej Kolar |
Unknown |
1 |
| #17 |
Carlota Supan |
— |
1 |
| #17 |
Edwin Stegovec |
— |
1 |